|
시장보고서
상품코드
2102222
항산화 능력 어세이 시장 규모, 점유율, 성장 분석 : 어세이 종류별, 제품 구성별, 최종 적용 분야별, 지역별 - 업계 예측(2026-2033년)Antioxidant Capacity Assays Market Size, Share, and Growth Analysis, By Assay Type (ORAC Assays, FRAP Assays), By Product Component (Reagent Kits, Instruments), By End Use Sector, By Region - Industry Forecast 2026-2033 |
||||||
세계의 항산화 능력 어세이 시장 규모는 2024년에 58억 4,000만 달러로 평가되었으며, 2025년 63억 3,000만 달러에서 2033년까지 120억 7,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 8.4%로 성장할 것으로 전망됩니다.
세계 항산화 능력 어세이 키트 시장은 식품, 의약품, 화장품 분야에서 필수적인 활성산소를 중화시키는 화합물의 능력을 측정하는 어세이 키트 및 기기가 특징입니다. 건강 증진 제품에 대한 소비자의 관심 증가와 검증된 항산화 효과에 대한 표시 규제의 강화가 시장 성장을 견인하고 있습니다. 형광법을 기반으로 한 분석법 및 자동화 플랫폼의 발전으로 도입률이 향상되고 있으며, 주요 기업들은 뉴트라슈티컬 개발자들의 요구에 부응하기 위해 제품 라인업을 확충하고 있습니다. 규제 당국의 감시가 강화됨에 따라 제조사들은 검증되고 GMP를 준수하는 키트에 대한 투자를 서두르고 있습니다. 또한, AI 기술은 데이터 해석을 자동화하고 처리 능력을 향상시킴으로써 이 분야에 혁명을 일으키고 있으며, 이를 통해 연구소는 더 많은 시료를 정확하고 효율적으로 처리할 수 있게 되어, 궁극적으로 항산화 시험에 대한 증가하는 수요를 충족시키는 데 기여합니다.
세계 항산화 능력 어세이 시장의 성장요인
산화 스트레스에 대한 소비자의 인식이 높아짐에 따라, 제약 회사와 생명공학 기업들은 신약 개발 초기 단계에 항산화 활성 분석을 도입하고 있습니다. 제품의 유효성과 안전성을 입증하는 데 중점을 두게 된 결과, 연구자들은 보호 효과를 강조하기 위해 이러한 분석법을 중요하게 여기게 되었습니다. 그 결과, 첨단 시험 플랫폼 및 시약에 대한 수요가 증가하고 있습니다. 기업들은 이러한 측정법을 적극적으로 도입함으로써 치료 후보 화합물의 인지 가치를 높이고, 분석 기술에 대한 추가 투자를 유도하고 있습니다. 이러한 추세는 다양한 치료 분야에서 항산화 능력 평가를 목적으로 하는 솔루션 세계 시장 확대에 기여하고 있습니다.
세계 항산화 능력 어세이법 시장의 제약요인
항산화 능력을 정확하게 측정하는 데 필요한 복잡한 화학 반응은 대개 고가의 독자 개발 시약에 의존하고 있어, 소규모 연구소나 신흥 시장 참여자들이 이를 이용하기 어려울 수 있습니다. 이러한 시약 구매에 따르는 높은 비용은 분석법의 광범위한 도입을 저해할 수 있으며, 기관들은 보다 저렴한 대체 분석법에 집중하게 됩니다. 그 결과, 특히 연구 자금이 제한적인 지역에서는 예산 제약이 시장 성장을 저해하고, 궁극적으로 고품질 항산화 분석 솔루션에 대한 수요를 둔화시키고 있습니다. 또한 이러한 재정적 과제는 분석법의 민감도와 효율성을 향상시킬 수 있는 첨단 기술의 도입도 방해하고 있습니다.
세계 항산화 능력 어세이 시장의 동향
세계 항산화 능력 어세이 시장은 고정밀 분석의 자동화가 급증함에 따라 강력한 변화를 겪고 있습니다. 연구 기관에서는 미세유체 처리, 고처리량 광학 시스템, AI를 활용한 데이터 분석을 적용한 첨단 자동화 플랫폼의 도입이 확대되고 있으며, 그 결과 수작업에 소요되는 시간과 결과의 편차가 대폭 감소하고 있습니다. 이러한 폐쇄형 시스템 장비로의 전환을 통해 엄격한 재현성을 확보하면서 다수의 시료를 동시에 처리할 수 있게 되어, 의약품 개발 및 식품 안전 검사의 효율이 향상되고 있습니다. 그 결과, 이 시장은 일관된 항산화 능력 어세이에 대한 규제 당국의 기대에 부응하고, 지속가능한 조사 관행을 촉진하며, 궁극적으로는 전 세계 공급망의 건전성을 뒷받침하는 데 기여하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 항산화 능력 어세이 시장 규모 : 어세이 종류별
세계의 항산화 능력 어세이 시장 규모 : 제품 구성별
세계의 항산화 능력 어세이 시장 규모 : 최종 적용 분야별
세계의 항산화 능력 어세이 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.05Global Antioxidant Capacity Assays Market size was valued at USD 5.84 Billion in 2024 and is poised to grow from USD 6.33 Billion in 2025 to USD 12.07 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).
The global antioxidant capacity assay market is characterized by analytical kits and instruments that measure the capability of compounds to neutralize reactive oxygen species, essential for the food, pharmaceutical, and cosmetic sectors. Increasing consumer interest in health-promoting products and mounting regulatory demands for validated antioxidant claims have driven market growth. Advancements in fluorescence-based assays and automated platforms have enhanced adoption rates, with leading companies expanding their product offerings to meet the needs of nutraceutical developers. Regulatory scrutiny has heightened, pushing manufacturers to invest in validated, GMP-compliant kits. Moreover, AI technology is revolutionizing this sector by automating data interpretation and enhancing throughput, enabling labs to process more samples accurately and efficiently, ultimately fulfilling the rising demand for antioxidant testing.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antioxidant Capacity Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Antioxidant Capacity Assays Market Segments Analysis
Global antioxidant capacity assays market is segmented by assay type, product component, end use sector and region. Based on assay type, the market is segmented into ORAC Assays, FRAP Assays, DPPH Assays, ABTS Assays and Others. Based on product component, the market is segmented into Reagent Kits, Instruments and Analysis Software. Based on end use sector, the market is segmented into Food Industry, Cosmetic Labs, Pharmaceutical R&D and Academic Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Antioxidant Capacity Assays Market
Increasing awareness among consumers regarding oxidative stress is motivating pharmaceutical and biotechnology companies to integrate antioxidant capacity assays into the early stages of drug development. This focus on demonstrating product efficacy and safety has led researchers to emphasize these assays to highlight protective effects. Consequently, there is a rising demand for sophisticated testing platforms and reagents. By proactively incorporating these measurements, companies enhance the perceived value of their therapeutic candidates, inviting further investment in assay technologies. This trend is contributing to the expansion of the global market for solutions aimed at evaluating antioxidant capacity across various therapeutic areas.
Restraints in the Global Antioxidant Capacity Assays Market
The intricate chemistry involved in accurately measuring antioxidant capacity frequently depends on proprietary reagents that are priced at a premium, which can restrict access for smaller laboratories and participants in emerging markets. The elevated costs associated with these acquisitions can deter widespread implementation of assays, leading organizations to focus on more affordable testing alternatives. As a result, budget limitations hinder market growth, especially in areas with limited research funding, ultimately dampening the demand for high-quality antioxidant assay solutions. These financial challenges also impede the integration of advanced technologies, which could improve the sensitivity and efficiency of assays.
Market Trends of the Global Antioxidant Capacity Assays Market
The Global Antioxidant Capacity Assays market is experiencing a robust transformation driven by a surge in precision assay automation. Laboratories are increasingly adopting advanced automated platforms that utilize microfluidic handling, high-throughput optics, and AI-driven data interpretation, resulting in significant reductions in hands-on time and variability in results. This shift towards closed-system instruments allows for concurrent processing of numerous samples while ensuring strict reproducibility, enhancing efficiency in pharmaceutical development and food safety testing. As a result, the market is aligning with regulatory expectations for consistent antioxidant measurements and fostering sustainable research practices, ultimately supporting the integrity of global supply chains.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Antioxidant Capacity Assays Market Size by Assay Type & CAGR (2026-2033)
- Market Overview
- ORAC Assays
- FRAP Assays
- DPPH Assays
- ABTS Assays
- Others
Global Antioxidant Capacity Assays Market Size by Product Component & CAGR (2026-2033)
- Market Overview
- Reagent Kits
- Instruments
- Analysis Software
Global Antioxidant Capacity Assays Market Size by End Use Sector & CAGR (2026-2033)
- Market Overview
- Food Industry
- Cosmetic Labs
- Pharmaceutical R&D
- Academic Research
Global Antioxidant Capacity Assays Market Size & CAGR (2026-2033)
- North America (Assay Type, Product Component, End Use Sector)
- US
- Canada
- Europe (Assay Type, Product Component, End Use Sector)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Assay Type, Product Component, End Use Sector)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Assay Type, Product Component, End Use Sector)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Assay Type, Product Component, End Use Sector)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Thermo Fisher Scientific Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sigma-Aldrich
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cayman Chemical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Biolabs Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioquochem S L
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Revvity Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Life Sciences Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Geno Technology Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kamiya Biomedical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RayBiotech Life Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arbor Assays Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
